SYMBICORT Medication Guide
SYMBICORT comes in 2 strengths. Your healthcare provider has prescribed the strength that is best for you. Note the differences between SYMBICORT and your other inhaled medications, including the differences in prescribed use and physical appearance.
Download SYMBICORT Medication Guide
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Imfinzi Full Prescribing Information
den8dhaj6zs0e.cloudfront.netlung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. (1.1) • in combination with etoposide and either carboplatin or cisplatin, as first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC). (1.2)
Lynparza Prescribing Information
den8dhaj6zs0e.cloudfront.net5.4 Venous Thromboembolic Events 6 ADVERSE REACTIONS 6.1 Clinical Trial Experience 6.2 Postmarketing Experience 7 DRUG INTERACTIONS 7.1 Use with Anticancer Agents 7.2 Effect of Other Drugs on Lynparza 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.3 Females and Males of Reproductive Potential 8.5 Geriatric Use 8.6 Renal Impairment
Information, Prescribing, Pregnancy, Prescribing information, Thromboembolic
BREZTRI Full Prescribing Information
den8dhaj6zs0e.cloudfront.netIf the inhaler has not been used for more than 7 days, is dropped, or after weekly . cleaning, prime the inhaler again by releasing 2 sprays into the air away from the face, shaking well before each spray. 2.3 Dose counter. BREZTRI AEROSPHERE canister has an attached dose indicator, which indicates . how many inhalations remain.
Information, Prescribing, Dose, Prescribing information, Inhaler
SYMBICORT Prescribing Information
den8dhaj6zs0e.cloudfront.net5.18 Hypokalemia and Hyperglycemia. 6 ADVERSE REACTIONS. 6.1 Clinical Trials Experience in Asthma 6.2 Clinical Trials Experience in Chronic Obstructive Pulmonary Disease. 6.3 Postmarketing Experience. 7 DRUG INTERACTIONS. Antidepressants 7.3 Beta-Adrenergic Receptor Blocking Agents 7.4 Diuretics. 8 USE IN SPECIFIC POPULATIONS. 8.1 Pregnancy …
US-56427 ---------------------------- DOSAGE AND ...
den8dhaj6zs0e.cloudfront.netnot start BRILINTA in patients undergoing urgent coronary artery bypass graft surgery (CABG). (5.1, 6.1) • If: possible, manage bleeding without discontinuing ----- BRILINTA. Stopping BRILINTA increases the risk of subsequent cardiovascular events. (5.4) ASPIRIN DOSE AND BRILINTA EFFECTIVENESS IN PATIENTS WITH ACS ...
Farxiga Prescribing Information
den8dhaj6zs0e.cloudfront.netpatients with polycystic kidney disease or patients requiring or with a recent . history of immunosuppressive therapy for the treatment of kidney disease. FARXIGA is not expected to be effective in these populations. (1)----- DOSAGE AND ADMINISTRATION ----- • Assess volume status and correct volume depletion before initiating. ...
Information, Disease, Prescribing, Kidney, Prescribing information, Kidney disease, Polycystic, Polycystic kidney disease
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE ...
den8dhaj6zs0e.cloudfront.netHealthcare Providers for detail on preparation and administration. (2) ... registered nurses, and physician assistants that are licensed or authorized under state law to prescribe drugs in the therapeutic class to which EVUSHELD belongs (i.e., anti-infectives).
CRESTOR PRESCRIBING INFORMATION
den8dhaj6zs0e.cloudfront.netreduce elevated total-C, LDL-C, ApoB, nonHDL-C, and TG levels and to increase HDL-C (1.1) ... Monitor INR frequently until stable upon initiation or alteration of CRESTOR therapy. (5.4, 7.6) • Concomitant lipid-lowering therapies: Use with fibrates or lipid-modifying doses (≥1 g/day)
Saphnelo full Prescribing Information
den8dhaj6zs0e.cloudfront.netwith severe active lupus nephritis or severe active central nervous system lupus. Use . of SAPHNELO is not recommended in these situations. (1)----- DOSAGE AND ADMINISTRATION -----The recommended dosage is 300 mg as an intravenous infusion over a 30-minute . …
CALQUENCE PRESCRIBING INFORMATION
den8dhaj6zs0e.cloudfront.netTable 1: Recommended Dose Modifications for Use with CYP3A Inhibitors or Inducers CYP3A Co-administered Drug Recommended CALQUENCE use Inhibition Strong CYP3A inhibitor Avoid concomitant use. If these inhibitors will be used short-term (such as anti-infectives for up to seven days), interrupt CALQUENCE. Moderate CYP3A inhibitor 100 mg once daily.
Related documents
How to Use Your Symbicort Inhaler(budesonide/formoterol)
www.med.umich.edu1. Remove Symbicort cap. Place middle or index finger on top of canister and thumb underneath the mouthpiece of the inhaler. 2. Shake inhaler for 5-10 seconds. 3. Breathe out fully (in preparation to breathe in medication). 4. Put the mouthpiece in your mouth and close your lips around it. Do not block the mouthpiece with your teeth or tongue. 5.
Step Therapy Medications
fm.formularynavigator.comautomated, electronic review of your medication history is performed to determine whether other medications have been tried first for your condition. This ensures clinically sound and cost-effective ... SYMBICORT) fluticasone-salmeterol inhalation aerosol powder breath activated 100-50 mcg/dose, 250-50 mcg/dose, 500-50 mcg/dose.
Your, Step, Medication, Therapy, Symbicort, Step therapy medications
Blue Cross Blue Shield of Michigan and Blue Care Network ...
www.bcbsm.comOur goals are to provide you with safe, high-quality prescription drug therapies and keep your medical costs low. To help accomplish this, we encourage the use of drugs that have similar effectiveness, quality and safety, but at a fraction of ... SYMBICORT AER 80-4.5, BREO ELLIPTA INH 100-25 . AJOVY INJ 225/1.5 . NON-PREFERRED BRAND .
Your, Cross, Michigan, Blue, Shield, Blue cross blue shield of michigan, Symbicort
Asthma care plan for education and care services
www.education.vic.gov.auOR Give 2 separate doses of a Bricanyl inhaler (age 6 & over) or a Symbicort inhaler (over 12). Wait 4 minutes — If there is no improvement, give 4 more separate puffs of blue/grey reliever as above (OR give 1 more dose of Bricanyl or Symbicort inhaler.) If there is still no improvement call emergency assistance (DIAL OOO)
How to Use Your Symbicort Inhaler(budesonide/formoterol)
www.med.umich.edu1. Remove Symbicort cap. Place middle or index finger on top of canister and thumb underneath the mouthpiece of the inhaler. 2. Shake inhaler for 5-10 seconds. 3. Breathe out fully (in preparation to breathe in medication). 4. Put the mouthpiece in your mouth and close your lips around it. Do not block the mouthpiece with your teeth or tongue. 5.
My Symbicort® SMART Asthma Action Plan - Moatfield
www.moatfield.co.ukto your doctor, as you may need to continue to do this. You can use Symbicort Turbohaler for symptoms brought on after exercise. HOW DO I USE IT? Your doctor or nurse will have given you full instructions on how to use Symbicort Turbohaler as Maintenance And Reliever Therapy, but here are some things to remember: • Take your regular daily ...
Long-Acting Muscarinic Antagonists (LAMAs)
www.nhlbi.nih.govcorticosteroid alone. If you already use an inhaled corticosteroid plus a LABA and your asthma still is not controlled, your health care provider may add a LAMA. If your health care provider prescribes a LAMA, make sure that you understand how to use the inhaler properly, because it may be different than those you are used to using.
Your, Long, Acting, Stagnation, How to use, Long acting muscarinic antagonists, Muscarinic
QUICK GUIDE TO USING YOUR SYMBICORT INHALER
www.symbicorttouchpoints.comYOUR SYMBICORT INHALER Before using SYMBICORT, read the full instructions in the patient information that comes with your prescription. You can use this quick reference guide as a brief reminder. If you have any questions, ask your doctor or pharmacist. PREPARING YOUR SYMBICORT INHALER Take your SYMBICORT inhaler out of the foil pouch.